Patents for A61P 35 - Antineoplastic agents (221,099)
03/2013
03/20/2013CN102973904A Drug for treatment and postoperative care of uterus myoma
03/20/2013CN102973896A Traditional Chinese medicine composition for treating tumor
03/20/2013CN102973893A Traditional Chinese medicine combination for treating cancers
03/20/2013CN102973892A Traditional Chinese medicine combination for treating breast cancer
03/20/2013CN102973830A Method for extracting flavonoid from asparagus
03/20/2013CN102973826A Chinese laxative drug for removing fire factor
03/20/2013CN102973808A Medicament for treating cancer
03/20/2013CN102973805A Traditional Chinese medicine composition for treating esophagus cancer
03/20/2013CN102973751A Antineoplastic agent
03/20/2013CN102973749A Preparation method and applications of divaricate saposhnikovia-angelica archang lica rhinitis tablets
03/20/2013CN102973735A Traditional Chinese medicine used for treating hysteromyoma
03/20/2013CN102973677A Traditional Chinese medicine for treating ovarian cyst
03/20/2013CN102973667A Preparation method and application of cold-fever tablet
03/20/2013CN102973636A Common threewingnut root microemlusion-based gel preparation and preparation method thereof
03/20/2013CN102973623A Separation method of ginseng rare saponins in ginseng fibrils
03/20/2013CN102973616A High-bioactivity ganoderma spore oil and supercritical preparation method thereof
03/20/2013CN102973605A Toad skin extract dry powder inhalant and preparation method and applications thereof
03/20/2013CN102973604A Toad skin extract dry powder inhalant and preparation method and applications thereof
03/20/2013CN102973573A Human breast cancer cell inhibitor and preparation method thereof
03/20/2013CN102973572A Cervical cancer cell inhibitor and preparation method thereof
03/20/2013CN102973550A Pharmaceutical composition for inhibiting cancer stem cell growth or cancer cell metastasis by using wogonin, and application thereof
03/20/2013CN102973549A Drug composition
03/20/2013CN102973528A Calcitriol solid lipidic dispersion and preparation method thereof
03/20/2013CN102973525A Antharcycline antitumor antibiotics loaded nano-micelle preparation and preparation method thereof
03/20/2013CN102973513A Intelligent nano-medicament delivery system and preparation method and application thereof
03/20/2013CN102973512A Adriamycin-loaded albumin nano-particle preparation with folate receptor targeting function and preparation method thereof
03/20/2013CN102973510A Method for preparing dual-function targeting quantum dot lipidosome
03/20/2013CN102973503A Norcantharidin derivative lipid microsphere injection and preparation method thereof
03/20/2013CN102973491A Nanoscale docetaxel and preparation method thereof
03/20/2013CN102973490A Nanoscale docetaxel and preparation method thereof
03/20/2013CN102973488A Nano-hydrogel with oxidation-reduction/pH double-stimulation responsiveness and preparation method and application thereof
03/20/2013CN102579360B Preparation method of 5-fluorouracil-carried pH-sensitive drug-bearing microsphere
03/20/2013CN102552185B 9-nitrocamptothecin mixed micelle freeze-dried powder injection and preparation method thereof
03/20/2013CN102525964B Gemcitabine hydrochloride lyophilized powder injection
03/20/2013CN102363019B Curcuma zedoary oil extract, preparation method thereof and purpose thereof
03/20/2013CN102351848B Rotenone cyclopropanecarboxamide and its preparation method and use
03/20/2013CN102335368B Decoction for treating cerebroma and application thereof
03/20/2013CN102327275B Application of 3-[4-(sulfonyl)benzene] urea compound in preparation of medicine for tumour
03/20/2013CN102319290B Medicament for preventing cancer cells from proliferating to lungs after radiation treatment of nasopharyngeal darcinoma
03/20/2013CN102304128B Heterocyclic naphthalimide derivative as well as preparation method and application thereof
03/20/2013CN102232943B Antrodia camphorata cyclohexenone compound for inhibiting skin cancer tumor cell growth
03/20/2013CN102178847B Vacuum freeze-drying processing method of dendrobium officinale
03/20/2013CN102160868B Application of astragaloside IV in preparing liver cancer resisting medicines
03/20/2013CN102145062B Active extracts of rosa roxburghii tratt fruit, and preparation method, detection method and application thereof
03/20/2013CN102126933B Diphenyl propane lignan compound and preparation method thereof
03/20/2013CN102125574B Medicinal composition for suppressing tumors
03/20/2013CN102101888B Novel polypeptide for resisting tumors caused by EB (Epstein-Barr) viruses, and application and preparation method thereof
03/20/2013CN102070556B 5-benzyl-4-alkyl-2-aminothiazole as well as preparation and application of 5-benzyl-4-alkyl-2-aminothiazole
03/20/2013CN102065865B Multiple myeloma treatments
03/20/2013CN102060793B Dual aryl tertiary amine azole compounds with biological activity as well as preparation method and medical application thereof
03/20/2013CN102058836B Medicament composition with effects of resisting thrombus, reducing blood pressure and treating leukemia
03/20/2013CN101991590B Stilbene glucoside medical composition and preparation method thereof
03/20/2013CN101928335B Fungus antitumor polypeptide nucleotide sequence, and preparation method and applications thereof
03/20/2013CN101917982B Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
03/20/2013CN101899051B 1-azaxanthone-3-formamide compounds as well as preparation method and antitumor application thereof
03/20/2013CN101856368B Crocodile choline, preparation method and application thereof
03/20/2013CN101843653B Processing method of Chinese stellera root condensed decoction
03/20/2013CN101838307B K2 polypeptide synthesis product and application thereof
03/20/2013CN101838306B K4 polypeptide synthesis product and application thereof
03/20/2013CN101735196B Method for synthesizing Imatinib
03/20/2013CN101677978B Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
03/20/2013CN101669936B Drug combination containing pratensein and application thereof in drugs
03/20/2013CN101648865B Polyphenol acrylic acid derivative and application thereof in medicaments
03/20/2013CN101624360B Substituted organic sulfur compound and application thereof
03/20/2013CN101619305B Antihuman CD52 monoclonal antibody hybridoma cell line, monoclonal antibody, engineered antibody, carrier, reagent kit and application thereof
03/20/2013CN101583357B Use of MTOR antagonist and angiogenesis inhibitor for preparing medicine for treating cancer
03/20/2013CN101538305B Method for preparing composite with antineoplastic activity by panoxadiol
03/20/2013CN101530589B Chinese medicinal preparation for treating cancers
03/20/2013CN101530464B Alcohol extract of walnut kernel and use thereof
03/20/2013CN101485665B Novel medical use of cucurbitacin
03/20/2013CN101475596B Platinum complexes of quercetin and derivatives thereof, as well as preparation and use thereof
03/20/2013CN101474186B 2,3,4,7,8-polysubstituted naphthyridine [4,3-d] pyridine derivates with anti-tumor activity
03/20/2013CN101439017B Method for preparing polymer aqueous solution formulation of taxane anti-tumor medicament
03/20/2013CN101390831B Docetaxel medical composition for injection and preparation method thereof
03/20/2013CN101247837B Novel salts of conjugated psychotropic drugs and processes of preparing same
03/20/2013CN101243043B Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
03/20/2013CN101237771B Multidrug resistant anticancer anthracyclines
03/19/2013US8399667 4-anilino quinazoline derivatives as antiproliferative agents
03/19/2013US8399617 Non-functional P2X7 receptor
03/19/2013US8399520 Selective estrogen receptor modulator
03/19/2013US8399479 Modulators of cystic fibrosis transmembrane conductance regulator
03/19/2013US8399477 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
03/19/2013US8399449 Fused heterocyclic derivative and use thereof
03/19/2013US8399435 Compounds for the treatment of proliferative disorders
03/19/2013US8399431 Cyclodextrin-based polymers for therapeutics delivery
03/19/2013US8399202 Peptides for development of diagnostic and therapeutic agents and methods of using same
03/19/2013US8398984 Removal promoters and inhibitor for apoptosis cells in vivo
03/19/2013US8398980 Subtypes of humanized antibody against interleuken-6 receptor
03/19/2013CA2733445C Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use
03/19/2013CA2706872C Intermediates for the preparation of lipoxin a4 analogs
03/19/2013CA2660799C Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof
03/19/2013CA2576191C T type calcium channel inhibitors
03/19/2013CA2556227C Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
03/19/2013CA2513251C Cancer therapy sensitizer
03/19/2013CA2491907C Oncolytic virus replicating selectively in tumor cells
03/19/2013CA2471702C Human monoclonal antibodies against cd30
03/19/2013CA2440303C Wt1 modified peptide
03/19/2013CA2435363C New inhibitors against galectins
03/19/2013CA2429342C Promoters exhibiting endothelial cell specificity and methods of using same
03/19/2013CA2367901C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases